Medtronic (MDT.US) Gains 4% Pre-Market on Strong Q2 Earnings Beat

Stock News11-18

On Tuesday, Medtronic PLC (MDT.US) rose 4% in pre-market trading to $100.14. The company reported Q2 FY2026 non-GAAP earnings per share (EPS) of $1.36, up from $1.26 a year earlier and surpassing the $1.31 consensus estimate from FactSet analysts.

Quarterly net sales reached $8.96 billion for the period ending October 24, compared to $8.4 billion in the prior-year quarter and exceeding the $8.87 billion analyst forecast.

For FY2026, Medtronic now projects non-GAAP EPS between $5.62 and $5.66, narrowing its prior guidance of $5.60–$5.66. The FactSet consensus stood at $5.62. The updated outlook includes an estimated $185 million tariff impact.

Additionally, the company raised its FY2026 revenue growth forecast to 5.5%, up from the previous 5% projection.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment